Christopher L. Moertel

4.7k total citations
78 papers, 2.2k citations indexed

About

Christopher L. Moertel is a scholar working on Neurology, Genetics and Molecular Biology. According to data from OpenAlex, Christopher L. Moertel has authored 78 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Neurology, 21 papers in Genetics and 16 papers in Molecular Biology. Recurrent topics in Christopher L. Moertel's work include Neurofibromatosis and Schwannoma Cases (24 papers), Glioma Diagnosis and Treatment (18 papers) and Neuroblastoma Research and Treatments (17 papers). Christopher L. Moertel is often cited by papers focused on Neurofibromatosis and Schwannoma Cases (24 papers), Glioma Diagnosis and Treatment (18 papers) and Neuroblastoma Research and Treatments (17 papers). Christopher L. Moertel collaborates with scholars based in United States, Canada and United Kingdom. Christopher L. Moertel's co-authors include Nigel S. Key, Stephen C. Nelson, Arne Slungaard, Frans A. Kuypers, Lori Styles, R Bach, Jan Watterson, L. H. Weiland, Robert L. Telander and David A. Largaespada and has published in prestigious journals such as Nature Genetics, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Christopher L. Moertel

75 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher L. Moertel United States	29	616	552	506	487	467	78	2.2k
Angela Mastronuzzi Italy	26	820 1.3×	422 0.8×	368 0.7×	262 0.5×	839 1.8×	190	2.4k
Alfonso Cerase Italy	31	436 0.7×	812 1.5×	297 0.6×	437 0.9×	430 0.9×	172	2.9k
Joachim Kühl Germany	24	1.1k 1.8×	596 1.1×	204 0.4×	409 0.8×	609 1.3×	59	2.1k
Álvaro Lassaletta Spain	26	714 1.2×	436 0.8×	306 0.6×	308 0.6×	442 0.9×	109	1.9k
Herbert E. Fuchs United States	27	531 0.9×	474 0.9×	188 0.4×	304 0.6×	431 0.9×	90	2.3k
Sandro Dallorso Italy	21	295 0.5×	517 0.9×	554 1.1×	375 0.8×	506 1.1×	78	1.8k
Hong Hoe Koo South Korea	34	1.4k 2.3×	575 1.0×	832 1.6×	381 0.8×	1.1k 2.4×	210	3.7k
Joanne Kurtzberg United States	25	484 0.8×	209 0.4×	673 1.3×	177 0.4×	461 1.0×	73	2.1k
Salvatore Bertolone United States	19	557 0.9×	296 0.5×	468 0.9×	210 0.4×	447 1.0×	61	1.7k
Richard L. Bakst United States	28	351 0.6×	186 0.3×	414 0.8×	665 1.4×	512 1.1×	156	3.1k

Countries citing papers authored by Christopher L. Moertel

Since Specialization

Citations

This map shows the geographic impact of Christopher L. Moertel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher L. Moertel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher L. Moertel more than expected).

Fields of papers citing papers by Christopher L. Moertel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher L. Moertel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher L. Moertel. The network helps show where Christopher L. Moertel may publish in the future.

Co-authorship network of co-authors of Christopher L. Moertel

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher L. Moertel. A scholar is included among the top collaborators of Christopher L. Moertel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher L. Moertel. Christopher L. Moertel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Williams, Kyle, Wendy A. Hudson, Gunda I. Georg, et al.. (2025). Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors. Molecular Cancer Therapeutics. 25(2). 230–243.

Moertel, Christopher L., Angela C. Hirbe, David Viskochil, et al.. (2024). ReNeu: A pivotal phase 2b trial of mirdametinib in children and adults with neurofibromatosis type 1 (NF1)-associated symptomatic inoperable plexiform neurofibroma (PN).. Journal of Clinical Oncology. 42(16_suppl). 3016–3016. 6 indexed citations

Forster, Colleen L., Carolina Sandoval-Garcia, Daniel Guillaume, et al.. (2023). MYO5A::FGFR1represents a novel fusion event in pediatric low-grade glioma. Neuro-Oncology Advances. 5(1). vdad017–vdad017. 1 indexed citations

Moertel, Christopher L., et al.. (2022). The Role of Socioeconomic Status and Race/Ethnicity in Malignant Peripheral Nerve Sheath Tumor Survival: A Surveillance, Epidemiology, and End Results–Based Analysis. Cancer Epidemiology Biomarkers & Prevention. 31(9). 1830–1838. 1 indexed citations

Spector, Logan G., et al.. (2020). Racial and ethnic disparities in survival of children with brain and central nervous tumors in the United States. Pediatric Blood & Cancer. 68(1). e28738–e28738. 20 indexed citations

Williams, Lindsay A., Christopher L. Moertel, Michaela Richardson, & Erin L. Marcotte. (2020). Incidence of second malignancies in individuals diagnosed with malignant peripheral nerve sheath tumors. Journal of Neuro-Oncology. 147(3). 701–709. 4 indexed citations

Xiong, Zhengming, G. Elizabeth Pluhar, Susan K. Rathe, et al.. (2019). CD200 Checkpoint Reversal: A Novel Approach to Immunotherapy. Clinical Cancer Research. 26(1). 232–241. 25 indexed citations

Nascene, David, et al.. (2019). Autonomic Cross-Innervation in Patients With Neurofibromatosis Type 2: Frey Syndrome and Unilateral Epiphora With Rhinorrhea. SHILAP Revista de lepidopterología. 6. 2329048X19866617–2329048X19866617. 1 indexed citations

Olin, Michael R., Christopher A. Pennell, Aaron L. Sarver, et al.. (2019). Treatment Combining CD200 Immune Checkpoint Inhibitor and Tumor-Lysate Vaccination after Surgery for Pet Dogs with High-Grade Glioma. Cancers. 11(2). 137–137. 31 indexed citations

10.

Foreman, Nicholas K., et al.. (2014). Pilomyxoid astrocytoma treated successfully with vemurafenib. Pediatric Blood & Cancer. 61(11). 2099–2100. 45 indexed citations

11.

Rahrmann, Eric P., Adrienne L. Watson, Vincent W. Keng, et al.. (2013). Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis. Nature Genetics. 45(7). 756–766. 108 indexed citations

12.

Moertel, Christopher L., et al.. (2013). A Novel APC Gene Mutation Associated With a Severe Phenotype in a Patient With Turcot Syndrome. Journal of Pediatric Hematology/Oncology. 36(3). e177–e179. 4 indexed citations

13.

Keng, Vincent W., Eric P. Rahrmann, Adrienne L. Watson, et al.. (2012). PTEN and NF1 Inactivation in Schwann Cells Produces a Severe Phenotype in the Peripheral Nervous System That Promotes the Development and Malignant Progression of Peripheral Nerve Sheath Tumors. Cancer Research. 72(13). 3405–3413. 67 indexed citations

14.

Moertel, Christopher L., et al.. (2009). Homozygous α-Thalassemia Treated with Intrauterine Transfusions and Unrelated Donor Hematopoietic Cell Transplantation. The Journal of Pediatrics. 154(5). 766–768. 28 indexed citations

15.

Tolar, Jakub, Gary R. Kravitz, K. Walker, & Christopher L. Moertel. (2001). ACUTE POLYOSTEAL OSTEOMYELITIS IN A PATIENT WITH CONGENITAL ICHTHYOSIS AND ACUTE LYMPHOBLASTIC LEUKEMIA. The Pediatric Infectious Disease Journal. 20(8). 813–814. 1 indexed citations

16.

Arndt, Carola A.S., Antonio G. Nascimento, G. Schroeder, et al.. (1998). Treatment of intermediate risk rhabdomyosarcoma and undifferentiated sarcoma with alternating cycles of vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide. European Journal of Cancer. 34(8). 1224–1229. 39 indexed citations

17.

Hilden, Joanne M., Jan Watterson, Darryl C. Longee, et al.. (1998). Central Nervous System Atypical Teratoid Tumor/Rhabdoid Tumor: Response to Intensive Therapy and Review of the Literature. Journal of Neuro-Oncology. 40(3). 265–275. 59 indexed citations

18.

Perkins, Joanna L., et al.. (1997). The Use of Implantable Venous Access Devices (IVADs) in Children with Hemophilia. The American journal of pediatric hematology/oncology. 19(4). 339–344. 47 indexed citations

19.

Johnson, Marilyn, Rachelle Nuss, Nigel S. Key, et al.. (1996). Lupus anticoagulant and protein S deficiency in children with postvaricella purpura fulminans or thrombosis. The Journal of Pediatrics. 128(3). 319–323. 132 indexed citations

20.

Moertel, Christopher L., Jan Watterson, Stanley R. McCormick, & Susan C. Simonton. (1995). Follicular large cell lymphoma of the testis in a child. Cancer. 75(5). 1182–1186. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact